Relapsed Non Hodgkin Lymphoma Recruiting Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02625480Study Evaluating KTE-X19 in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaTreatment
NCT03778619MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell OriginTreatment